FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q2 EPS of $2.55, $0.26 worse than the analyst estimate of $2.81. Revenue for the quarter came in at $153.6 million versus the consensus estimate of $197.34 million.
GUIDANCE:
Fulgent Genetics, Inc. sees FY2021 EPS of $12.50, versus the consensus of... More

